modipafant has been researched along with Asthma, Bronchial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angus, RM; Barnes, NC; Barnes, PJ; Bone, MF; Chung, KF; Fairfax, AJ; Higenbotham, TW; Kuitert, LM; O'Connor, BJ; Piotrowska, B | 1 |
| Barnes, NC; Burke, W; Hui, KP; Kuitert, LM; Newland, AC; Uden, S; Uthayarkumar, S | 1 |
2 trial(s) available for modipafant and Asthma, Bronchial
| Article | Year |
|---|---|
Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma.
Topics: Adult; Aged; Asthma; Dihydropyridines; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Imidazoles; Male; Middle Aged; Peak Expiratory Flow Rate; Platelet Activating Factor; Quality of Life; Single-Blind Method | 1995 |
Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen.
Topics: Adolescent; Adult; Allergens; Asthma; Bronchial Provocation Tests; Dihydropyridines; Double-Blind Method; Forced Expiratory Volume; Humans; Imidazoles; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation | 1993 |